IDENTIFICATION OF POTENTIAL HCV INHIBITORS BASED ON THE INTERACTION OF EPIGALLOCATECHIN-3-GALLATE WITH VIRAL ENVELOPE PROTEINS

Identification of Potential HCV Inhibitors Based on the Interaction of Epigallocatechin-3-Gallate with Viral Envelope Proteins

Hepatitis C is affecting millions of people around the globe annually, which leads to death in very high numbers.After many years of research, hepatitis C virus (HCV) remains a serious threat to the human population and needs proper management.The in silico approach in the drug discovery process is an efficient method in identifying inhibitors for

read more